Physiotherapy publishes empirical (research) and review (theoretical) works, including clinical commentaries. We strive to ensure that our articles are of interest to all physiotherapists and their patients, and to the wider medical community.
The authors acknowledge the contributions of their co-authors, who have assisted with the development and/or editing of this article. The authors also acknowledge the contribution of the editor-in-chief and the editorial team to the quality of this work.
A survey of front-line physiotherapists during the COVID-19 pandemic in Nigeria revealed that they did not receive appropriate training for their roles in managing the health promotion, disease prevention, treatment and rehabilitation of patients with COVID-19. This may have contributed to the low utilisation of physiotherapy in these patients.
To assess whether high frequency chest compression (HFCC) could be an effective alternative to conventional physiotherapy for clearing bronchial secretions in cystic fibrosis (CF) patients admitted to hospital with acute pulmonary exacerbation. Both HFCC and CPT improved symptoms, pulmonary function tests (PFTs) and functional capacity on discharge.
A survey of physiotherapists who presented abstracts at an Australian Physiotherapy Association conference indicated that whilst most experimental research involving humans involved HREC approval, only 47% reported reading or referring to the ethical documents governing human research. This has implications for tertiary education programs, researchers and physiotherapy managers. We recommend that all physiotherapists follow best practice for ethical considerations when undertaking research involving humans.